Ten investors collectively hold a majority stake of 50% in Achieve Life Sciences, with institutional investors owning the largest share at 46%. The company's stock is under $10bn market cap, making it an attractive investment opportunity for those interested in AI's impact on healthcare.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing